(Q24801879)

English

Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis--practical aspects at the bedside and patient identification

scientific article published on June 30, 2003

In more languages

Statements

scholarly article

0 references

10 references

22 March 2019

25 April 2019

17 June 2019

22 June 2019

4 August 2019

18 November 2019

27 November 2019

21 December 2019

1 February 2021

26 April 2021

Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis--practical aspects at the bedside and patient identification (English)

0 references

2 references

1 February 2021

26 April 2021

1 reference

4 August 2019

1 reference

18 November 2019

1 reference

27 November 2019

protein precursor

1 reference

21 December 2019

recombinant protein

1 reference

21 December 2019

Protein C, inactivator of coagulation factors Va and VIIIa

1 reference

1 February 2021

intracranial hemorrhage

1 reference

26 April 2021

drotrecogin alfa

1 reference

based on heuristic

inferred from title

author name string

Pierre-François Laterre

1

0 references

Xavier Wittebole

2

0 references

language of work or name

0 references

publication date

December 2003

0 references

1 December 2003

10 references

22 March 2019

25 April 2019

17 June 2019

22 June 2019

4 August 2019

18 November 2019

27 November 2019

21 December 2019

1 February 2021

26 April 2021

30 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624684

3 April 2024

full work available at URL

https://ccforum.biomedcentral.com/counter/pdf/10.1186/cc2342

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624684

3 April 2024

https://europepmc.org/articles/PMC374360

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624684

3 April 2024

https://europepmc.org/articles/PMC374360?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624684

3 April 2024

10 references

22 March 2019

25 April 2019

17 June 2019

22 June 2019

4 August 2019

18 November 2019

27 November 2019

21 December 2019

1 February 2021

26 April 2021

7

0 references

6

0 references

445-50

0 references

Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

7 April 2017

Activation of endothelial cell protease activated receptor 1 by the protein C pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

7 April 2017

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

7 April 2017

APACHE II: a severity of disease classification system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

7 April 2017

Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

28 September 2017

Management of patients with severe sepsis, treated by drotrecogin alfa (activated).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

28 September 2017

Risk-benefit analysis for drotrecogin alfa (activated).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

28 September 2017

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

28 September 2017

Spontaneous intracerebral hemorrhage in critically ill patients: incidence over six years and associated factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

28 September 2017

The protein C anticoagulant pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

28 September 2017

Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

28 November 2018

Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

28 November 2018

Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=374360

28 November 2018

Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland

1 reference

https://pubmed.ncbi.nlm.nih.gov/14624684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of stroke and death in patients with aortic and mitral valve endocarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14624684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/14624684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24801879&oldid=2175262930"